Moore Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,000
Closed -$11.8M 741
2025
Q4
$11.8M Buy
+11,000
New +$10.5M 0.17% 142
2025
Q3
Sell
-24,000
Closed -$18.7M 688
2025
Q2
$18.7M Buy
+24,000
New +$18.6M 0.23% 86
2024
Q3
Sell
-21,000
Closed -$19M 522
2024
Q2
$19M Sell
21,000
-8,000
-28% -$6.4M 0.33% 91
2024
Q1
$22.6M Sell
29,000
-25,000
-46% -$17.8M 0.36% 67
2023
Q4
$31.5M Buy
+54,000
New +$31.5M 0.54% 32
2023
Q3
Sell
-22,200
Closed -$10.4M 549
2023
Q2
$10.4M Buy
+22,200
New +$9.31M 0.18% 90
2022
Q4
Sell
-89,980
Closed -$29.1M 594
2022
Q3
$29.1M Buy
89,980
+9,680
+12% +$3.07M 0.68% 26
2022
Q2
$26M Buy
+80,300
New +$24.1M 0.69% 22
2021
Q3
Sell
-33,545
Closed -$7.7M 841
2021
Q2
$7.7M Buy
+33,545
New +$6.74M 0.11% 166
2020
Q1
Sell
-83,162
Closed -$10.9M 222
2019
Q4
$10.9M Buy
+83,162
New +$9.64M 0.36% 81
2019
Q3
Sell
-63,176
Closed -$7M 349
2019
Q2
$7M Sell
63,176
-17,729
-22% -$2.09M 0.16% 127
2019
Q1
$10.5M Buy
80,905
+34,546
+75% +$4.2M 0.32% 90
2018
Q4
$5.37M Buy
+46,359
New +$5.18M 0.21% 80
2016
Q2
Sell
-50,000
Closed -$3.6M 302
2016
Q1
$3.6M Buy
+50,000
New +$3.78M 0.15% 147

Other funds holding LLY

Moore Capital Management's LLY Position: Q1 2026 in Review

Moore Capital Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 11,000 shares — an estimated $11.8M sold.

Moore Capital Management first reported a position in LLY in Q1 2016 and held it in 14 quarters. The position peaked at $31.5M in Q4 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Moore Capital Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Moore Capital Management sold 11,000 Eli Lilly shares in Q1 2026, an estimated $11.8M.
  • Moore Capital Management first reported a position in Eli Lilly in Q1 2016 and held it in 14 quarters.
  • Moore Capital Management's Eli Lilly position peaked at $31.5M in Q4 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.